Announcements

We are pleased to inform you that Biomedicines (ISSN: 2227-9059) received an updated Impact Factor of 4.7. Biomedicines now ranks in the top 25% in the “Pharmacology & Pharmacy” category. Our journal is continuing to build momentum in biomedicines.

Biomedicines ranks as follows:

• Q1 (69 out of 277 journals) in the "Pharmacology & Pharmacy" category;
• Q2 (54 out of 136 journals) in the "Medicine, Research & Experimental" category;
• Q2 (92 out of 285 journals) in the "Biochemistry & Molecular Biology"

For more journal statistics, please visit https://www.mdpi.com/journal/biomedicines/stats.

The Biomedicines Editorial Office would like to thank all authors, reviewers, and editors who have contributed to the journal.

MDPI will attend the ESMO Congress 2023 as an exhibitor. This conference will be held in Madrid, Spain, from 20 to 24 October 2023.

The ESMO Congress is the most influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. They will disseminate the latest cutting-edge data, provide high-quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.

The following MDPI journals will be represented:

• Cancers;
• JCM;
• Cells;
• Diagnostics;
• Medical Sciences;
• Biomedicines;
• Geriatrics;
• Current Oncology;
• Hemato;
• Onco;
• CIMB;
• Healthcare.

If you are attending this conference, please feel free to start a conversation with us at our booth #724. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.esmo.org/meeting-calendar/esmo-congress-2023.

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.

Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.

Source: 2022 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2023)

Conference: 2023 Chinese Biophysics Congress
Date: 19–23 July 2023
Place: Changsha, China

MDPI will be attending the 2023 Chinese Biophysics Congress, which will be held from 19 to 23 July 2023 in Changsha, China.

The Chinese Biophysics Congress is the largest and most developed academic event in the field of biophysics in China. Prof. Tao Xu, the chairman of the Chinese Society of Biophysics, will be the chair of the organizing committee. The main theme is Biophysics and Human Health, focusing on the latest research progress and development trend of biophysics and related research fields.

The following MDPI journals will be represented:

• IJMS;
• Biophysica;
• Biomedicines;
• Physics;
• CIMB;
• Bioengineering;
• Biomolecules.

Please do not hesitate to reach out (ijms@mdpi.com) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have. For more information about the conference, please visit the following website: https://www.bsc.org.cn/2023/.

Conference: WASOG 2023

Organization: The World Association of Sarcoidosis and Other Granulomatous Disorders

Date: 19–21 June 2023

Place: Aula Medica, Karolinska Institutet, Stockholm, Sweden

Booth: #7

MDPI will be attending the WASOG 2023 conference, which will be held from 19 to 21 June 2023 at Aula Medica, Karolinska Institutet, Stockholm, Sweden.

WASOG 2023 will offer a creative meeting ground for investigating how novel experimental, theoretical and computational approaches in Sarcoidosis and Interstitial Lung Diseases (ILDs) can improve our understanding of their underlying disease mechanisms. It aims to build an even stronger scientific bridge between different sectors, ultimately closing the knowledge gap and accelerating the development and spread of precision medicine in ILDs.

The following MDPI journals will be represented:

• Biomedicines;
• Clinics and Practice;
• Diagnostics;
• Diseases;
• Genes;
• Healthcare;
• Hematology Reports;
• IJTM;
• JCM;
• Medicines;
• Reports.

Please reach out (diagnostics@mdpi.com) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

MDPI journals will be attending the 42nd annual meeting of the American Society for Virology as an exhibitor. This meeting will be held in Athens, Georgia, USA from 24 to 28 June 2023.

The American Society for Virology (ASV) is a wonderful community that brings together virologists from all areas of the field. As a result, the annual meetings are rich in diverse scientific offerings and they can be quite large (sometimes over 1600 attendees). This conference is hosted by the University of Georgia and held at the Classic Center; the scientific program will include symposia, concurrent workshops, poster sessions, exhibits, and special events. Professional development activities and social events will be interspersed throughout the meeting.

The following MDPI journals will be represented:

• Biomedicines;
• Life;
• Viruses;
• Cells;
• Vaccines;
• Veterinary Sciences;
• Microorganisms;
• CIMB;
• Pathogens;
• TropicalMed;
• Zoonotic Diseases;
• COVID.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference and our booth, please visit: https://asv.org/asv2023/.

Today, we have clear evidence that HDPs have far more than broad-spectrum antimicrobial activity, including immunomodulatory effects, wound healing, LPS neutralization, chemotaxis, or anti-cancer effects. Moreover, the multifunctionality of HDPs has resulted in a lot of interest in the development of new therapeutic strategies against infectious diseases.

The “Antimicrobial Peptides AKA Host Defense Peptides” webinar will present the latest research on multifunctional host defense molecules. The webinar will cover a wide range of topics, such as structure/function studies, regulation of expression, mechanisms of action, and development of antimicrobial peptides as therapeutics. Invited speakers will represent cross-disciplinary research, including biochemistry, microbiology, structural biology, medicine, innate immunity, signaling, and drug development.

Date: 31 May 2023 at 10:00 a.m. CEST | 4:00 a.m. EDT | 4:00 p.m. CST Asia
Webinar ID: 893 2420 8525

Register now for free!

Program

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway and we’ll let you know when the recording is available to watch.

Webinar Chair and Keynote Speakers:

• Jitka Petrlova, Department of Clinical Sciences, Division of Dermatology and Venereology, Lund University, Lund, Sweden;
• Parveen Papareddy, Department of Clinical Sciences, Division of Infection Medicine, Lund University, Lund, Sweden;
• Dr. Ester Boix, Department of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.

Relevant Special Issues:
“Antimicrobial Peptides Aka Host Defense Peptides – from Basic Research to Therapy”
Guest Editor: Dr. Jitka Petrlova 

“Antimicrobial Peptides Aka Host Defense Peptides – from Basic Research to Therapy 2.0”
Guest Editor: Dr. Jitka Petrlova

Conference: 8th European Congress of Virology 2023
Date: 4–7 May 2023
Location: Gdańsk, Poland

MDPI will be attending the 8th European Congress of Virology 2023 (ECV 2023) as an exhibitor, and we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference is organized by the European Society for Virology. ECV 2023 will be a great opportunity for European virologists representing various fields of research to meet, present their results, and discuss all the developments in virology that have taken place during this unusual time. It will also be a great opportunity to meet friends, renew old acquaintances, and establish new collaborations. Although coronavirus studies will undoubtedly be one of the leading subjects at ECV 2023, it is important to have all research areas represented, including basic, clinical, veterinary, and plant virology. 

The following MDPI journals will be represented:

• Viruses;
• Microorganism;
• Vaccines;
• Pathogens;
• Biomedicines;
• Veterinary Science;
• Immuno;
• COVID.

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.eusv-congress.eu/.

This conference organized by the British Pharmacological Society and International Union of Basic and Clinical Pharmacologists (IUPHAR) will be held in Glasgow, Scotland, from 2 July to 7 July 2023. The topic of the conference focuses on pharmacology and drug discovery, research, and development, and the conference will include six days of symposia, keynote lectures, workshops, and debates. Discover the latest in pharmacology research and developments across 10 content themes.

Pharmaceuticals (ISSN: 1424-8247) is a peer-reviewed, open access journal of medicinal chemistry and related drug sciences, published monthly online by MDPI. Pharmaceuticals will participate in this event as an exhibitor together with nine other MDPI journals, among which Pharmaceuticals, Journal of Personalized Medicine and Biomedicines will have journal representatives at our booth.

The following MDPI journals will be represented:

• Pharmaceuticals (leading journal);
• Biomedicines;
• JPM;
• JCM;
• Marine Drugs;
• Children;
• Current Oncology;
• BioMedInformatics;
• JoX;
• Rheumato.

If you are attending this conference, please feel free to start a conversation with us at our booth #A22. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://wcp2023.org/ or contact the Pharmaceuticals Editorial Office at pharmaceuticals@mdpi.com.